BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 15769782)

  • 1. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene.
    Villard E; Duboscq-Bidot L; Charron P; Benaiche A; Conraads V; Sylvius N; Komajda M
    Eur Heart J; 2005 Apr; 26(8):794-803. PubMed ID: 15769782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in sarcomere protein genes in left ventricular noncompaction.
    Klaassen S; Probst S; Oechslin E; Gerull B; Krings G; Schuler P; Greutmann M; Hürlimann D; Yegitbasi M; Pons L; Gramlich M; Drenckhahn JD; Heuser A; Berger F; Jenni R; Thierfelder L
    Circulation; 2008 Jun; 117(22):2893-901. PubMed ID: 18506004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy.
    Liu SX; Hu SJ; Sun J; Wang J; Wang XT; Jiang Y; Cai J
    Eur J Intern Med; 2005 Sep; 16(5):328-33. PubMed ID: 16137545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region.
    Hougs L; Havndrup O; Bundgaard H; Køber L; Vuust J; Larsen LA; Christiansen M; Andersen PS
    Eur J Hum Genet; 2005 Feb; 13(2):161-5. PubMed ID: 15483641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial and sporadic hypertrophic myopathy: differences and similarities in a genotyped population. A long follow-up study.
    Brito D; Richard P; Komajda M; Madeira H
    Rev Port Cardiol; 2008 Feb; 27(2):147-73. PubMed ID: 18488914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
    Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
    J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy].
    García-Castro M; Coto E; Reguero JR; Berrazueta JR; Alvarez V; Alonso B; Sainz R; Martín M; Morís C
    Rev Esp Cardiol; 2009 Jan; 62(1):48-56. PubMed ID: 19150014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Family hypertrophic cardiomyopathy caused by a 14035c > t mutation in cardiac troponin T gene].
    Wang SX; Zou YB; Fu CY; Song L; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):371-4. PubMed ID: 17456375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
    Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
    N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain.
    Bundgaard H; Havndrup O; Andersen PS; Larsen LA; Brandt NJ; Vuust J; Kjeldsen K; Christiansen M
    J Mol Cell Cardiol; 1999 Apr; 31(4):745-50. PubMed ID: 10329202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations profile in Chinese patients with hypertrophic cardiomyopathy.
    Song L; Zou Y; Wang J; Wang Z; Zhen Y; Lou K; Zhang Q; Wang X; Wang H; Li J; Hui R
    Clin Chim Acta; 2005 Jan; 351(1-2):209-16. PubMed ID: 15563892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy.
    Yang JH; Zheng DD; Dong NZ; Yang XJ; Song JP; Jiang TB; Cheng XJ; Li HX; Zhou BY; Zhao CM; Jiang WP
    Chin Med J (Engl); 2006 Nov; 119(21):1785-9. PubMed ID: 17097032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease.
    Yu B; Sawyer NA; Caramins M; Yuan ZG; Saunderson RB; Pamphlett R; Richmond DR; Jeremy RW; Trent RJ
    J Clin Pathol; 2005 May; 58(5):479-85. PubMed ID: 15858117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
    Kaski JP; Syrris P; Esteban MT; Jenkins S; Pantazis A; Deanfield JE; McKenna WJ; Elliott PM
    Circ Cardiovasc Genet; 2009 Oct; 2(5):436-41. PubMed ID: 20031618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic distal myopathy with cardiomyopathy due to a MYH7 mutation.
    Overeem S; Schelhaas HJ; Blijham PJ; Grootscholten MI; ter Laak HJ; Timmermans J; van den Wijngaard A; Zwarts MJ
    Neuromuscul Disord; 2007 Jun; 17(6):490-3. PubMed ID: 17383184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.